Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Camostat (mesylate)

Camostat mesylate (Camostat mesilate) is an orally active, synthetic serine protease inhibitor for chronic pancreatitis. Camostat mesylate, an inhibitor of TMPRSS2, shows antiviral activity against SARS-CoV-2. Camostat mesylate also inhibits the activity of prostasin, trypsin, and matriptase[1][2][3].

Product Specifications

CAS Number

[59721-29-8]

Product Name Alternative

Camostat mesilate; FOY305; FOY-S980

UNSPSC

12352005

Hazard Statement

H315, H319, H335, H400

Target

SARS-CoV; Ser/Thr Protease

Type

Reference compound

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

Cancer-Kinase/protease

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/Camostat-mesylate.html

Purity

99.94

Solubility

DMSO : 125 mg/mL (ultrasonic) |H2O : ≥ 50 mg/mL

Smiles

O=C(OCC(N(C)C)=O)CC1=CC=C(OC(C2=CC=C(NC(N)=N)C=C2)=O)C=C1.CS(=O)(O)=O

Molecular Formula

C21H26N4O8S

Molecular Weight

494.52

Precautions

H315, H319, H335, H400

References & Citations

[1]Gibo J, et al. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. Lab Invest. 2005;85 (1) :75‐89.|[2]Uno Y. Camostat mesilate therapy for COVID-19 [published online ahead of print, 2020 Apr 29]. Intern Emerg Med. 2020;1‐2.|[3]Coote K, et al. Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. J Pharmacol Exp Ther. 2009;329 (2) :764‐774.|[4]Zhou Y, Vedantham P, Lu K, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015;116:76‐84.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Launched

Citation 01

Am J Physiol Renal Physiol. 2024 Aug 1;327 (2) :F265-F276.|Antiviral Res. 2023 Jun:214:105606.|Biochem Pharmacol. 2023 Jul:213:115617.|Biosaf Health. 2022 Feb;4 (1) :38-44.|Cell Discov. 2021 Dec 14;7 (1) :119.|Cell Prolif. 2025 May 15:e70060.|Cell Rep Med. 2022 Sep 20;3 (9) :100743.|Cell. 2023 Feb 16;186 (4) :850-863.e16.|EBioMedicine. 2023 Sep:95:104753.|Emerg Microbes Infect. 2022 Dec;11 (1) :2275-2287.|Eur J Med Chem. 2021 Nov 15:224:113683.|Eur J Pharmacol. 2022 Mar 15:919:174795.|Eur J Pharmacol. 2023 Jan 5:938:175394.|Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Transmissores de Hematozoários. 2020 Sep.|J Virol. 2023 May 31;97 (5) :e0032423.|J Virol. 2025 Nov 18:e0127425.|mBio. 2022 Dec 20;13 (6) :e0256622.|Nat Chem Biol. 2022 Sep;18 (9) :963-971.|Nat Commun. 2022 Jul 26;13 (1) :4331.|Nat Commun. 2022 Mar 17;13 (1) :1444.|Nat Commun. 2024 Jul 3;15 (1) :5606.|Nat Commun. 2024 Oct 9;15 (1) :8728.|Nat Commun. 2025 Jul 7;16 (1) :6241.|Nat Microbiol. 2024 Sep;9 (9) :2383-2394.|Nat Microbiol. 2025 Oct 30, 10 (11) :2860-2874.|Nature. 2022 Mar;603 (7902) :693-699.|Nucleic Acids Res. 2021 Jan 8;49 (D1) :D1113-D1121.|Proc Natl Acad Sci U S A. 2022 Jan 25;119 (4) :e2117576119.|Res Sq. 2023 Sep 11:rs.3.rs-3220157.|Res Sq. 2024 Nov 21.|Research Square Preprint. 2022 Jan.|Sci Adv. 2023 Jan 20;9 (3) :eadd3867.|Sci China Life Sci. 2025 Oct 24.|Sci Signal. 2024 Aug 20;17 (850) :eadn3785.|Signal Transduct Target Ther. 2022 Mar 11;7 (1) :83.|SSRN. 2020 Jun.|SSRN. 2024 Jan 26.|SSRN. 2024 Jul 11.|Utrecht University. CENTER FOR CELL IMAGING. 2022 Jul.|Viruses. 2022 Feb 8;14 (2) :353.|J Virol. 2025 Aug 11:e0105525.|PLoS Pathog. 2025 Oct 14;21 (10) :e1013593.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CDC16 Antibody
MBS7127852-01 0.05 mL

CDC16 Antibody

Ask
View Details
CDC16 Antibody
MBS7127852-02 0.1 mL

CDC16 Antibody

Ask
View Details
CDC16 Antibody
MBS7127852-03 5x 0.1 mL

CDC16 Antibody

Ask
View Details
Lentiviral human CIART sgRNA gene knockout kit - Lentiviral human CIART sgRNA gene knockout kit (plasmid)
GTR15401483 1 Vial

Lentiviral human CIART sgRNA gene knockout kit - Lentiviral human CIART sgRNA gene knockout kit (plasmid)

Ask
View Details
Anti-DENV-2 NSP5/NS5 Antibody (1A1)
MBS1572250-01 0.1 mg

Anti-DENV-2 NSP5/NS5 Antibody (1A1)

Ask
View Details
Anti-DENV-2 NSP5/NS5 Antibody (1A1)
MBS1572250-02 1 mg

Anti-DENV-2 NSP5/NS5 Antibody (1A1)

Ask
View Details